Most cited papers in Smoking Behavior and Cessation
What are the most cited papers in Smoking Behavior and Cessation?
The most cited paper in Smoking Behavior and Cessation is "Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues" (Haider Raza, Annie John, Abderrahim Nemmar, 2013), with 47,289 citations. Next come "The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire" (10,879) and "Actual Causes of Death in the United States, 2000" (5,270).
Showing 50 of 99 papers. Every paper with more than 1,004 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues Haider Raza, Annie John, Abderrahim Nemmar · Cellular Physiology and Biochemistry | 2013 | 47,289 |
| 2 | The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire Todd F. Heatherton, Lynn T. Kozlowski, Richard C. Frecker et al. · British Journal of Addiction | Sep 1991 | 10,879 |
| 3 | Actual Causes of Death in the United States, 2000 Ali H. Mokdad · JAMA | 9 Mar 2004 | 5,270 |
| 4 | Current Cigarette Smoking Among Adults - United States, 2016. Ahmed Jamal, Elyse Phillips, Andrea S. Gentzke et al. · PubMed | 28 Nov 2014 | 2,666 |
| 5 | Current Cigarette Smoking Among Adults — United States, 2005–2014 Ahmed Jamal, David M. Homa, Erin L. O’Connor et al. · MMWR Morbidity and Mortality Weekly Report | 10 Nov 2015 | 2,559 |
| 6 | Smoking and Mental Illness Karen E. Lasser, J. Wesley Boyd, Steffie J. Woolhandler et al. · JAMA | 22 Nov 2000 | 2,530 |
| 7 | Use of mass media campaigns to change health behaviour Melanie A Wakefield, Barbara Loken, Robert C Hornik · The Lancet | Oct 2010 | 2,522 |
| 8 | Nicotine replacement therapy for smoking cessation Lindsay F Stead, Rafael Perera, Chris Bullen et al. · Cochrane Database of Systematic Reviews | 8 Nov 2012 | 2,483 |
| 9 | The Collective Dynamics of Smoking in a Large Social Network Nicholas A. Christakis, James H. Fowler · New England Journal of Medicine | 21 May 2008 | 2,433 |
| 10 | The natural history of chronic airflow obstruction. Charles M Fletcher, Richárd Pető · BMJ | 25 Jun 1977 | 2,387 |
| 11 | Fine-Particulate Air Pollution and Life Expectancy in the United States C. Arden Pope, Majid Ezzati, Douglas W. Dockery · New England Journal of Medicine | 21 Jan 2009 | 2,327 |
| 12 | Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Seth M. Noar, Christina Benac, Melissa S. Harris · Psychological Bulletin | 2007 | 2,185 |
| 13 | The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. Carlo C. DiClemente, James O. Prochaska, Scott Fairhurst et al. · Journal of Consulting and Clinical Psychology | 1991 | 2,147 |
| 14 | Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 Marissa Bettay Reitsma et al. · The Lancet | 5 Apr 2017 | 2,085 |
| 15 | Adolescent Sexual Behavior, Drug Use, and Violence: Increased Reporting with Computer Survey Technology Charles F. Turner, Leighton C. Ku, Susan Rogers et al. · Science | 8 May 1998 | 2,064 |
| 16 | Smoking and drinking in relation to oral and pharyngeal cancer. William J. Blot, Joseph K. McLaughlin, Deborah M. Winn et al. · PubMed | Jun 1988 | 2,020 |
| 17 | Physician advice for smoking cessation Lindsay F Stead, Diana Buitrago, Nataly Preciado et al. · Cochrane Database of Systematic Reviews | 28 May 2013 | 1,923 |
| 18 | Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries Mattias Öberg, Maritta S. Jaakkola, Alistair J Woodward et al. · The Lancet | 27 Nov 2010 | 1,910 |
| 19 | 21st-Century Hazards of Smoking and Benefits of Cessation in the United States Prabhat Jha, Chinthanie F. Ramasundarahettige, Victoria Landsman et al. · New England Journal of Medicine | 23 Jan 2013 | 1,809 |
| 20 | Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 Marissa Bettay Reitsma et al. · The Lancet | 27 May 2021 | 1,767 |
| 21 | The validity of self-reported smoking: a review and meta-analysis. Donald L. Patrick, Allen D. Cheadle, D. C. Thompson et al. · American Journal of Public Health | Jul 1994 | 1,761 |
| 22 | Levels of selected carcinogens and toxicants in vapour from electronic cigarettes Maciej Lukasz Goniewicz, Jakub Knysak, Michał Gawron et al. · Tobacco Control | 6 Mar 2013 | 1,741 |
| 23 | Cigarette smoking among adults — United States, 1988 Jerald G. Bachman, Lloyd D. Johnston, Patrick M. O’Malley · Patient Education and Counseling | Jun 1992 | 1,711 |
| 24 | Signs and Symptoms of Tobacco Withdrawal John R. Hughes · Archives of General Psychiatry | Mar 1986 | 1,678 |
| 25 | Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial Douglas E. Jorenby · JAMA | 5 Jul 2006 | 1,655 |
| 26 | Spatial disease clusters: Detection and inference Martin Kulldorff, Neville Nagarwalla · Statistics in Medicine | 30 Apr 1995 | 1,630 |
| 27 | Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire Karl O. Fagerström, Nina G. Schneider · Journal of Behavioral Medicine | Apr 1989 | 1,621 |
| 28 | A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking Cessation Douglas E. Jorenby, Scott James Leischow, Mitchell A. Nides et al. · New England Journal of Medicine | 4 Mar 1999 | 1,609 |
| 29 | Socioeconomic status and smoking: a review Rosemary Hiscock, Linda Bauld, Amanda Amos et al. · Annals of the New York Academy of Sciences | 17 Nov 2011 | 1,608 |
| 30 | Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012 Marie Ng, Michael K Freeman, Thomas Fleming et al. · JAMA | 7 Jan 2014 | 1,601 |
| 31 | Psychological Predictors of Problem Mobile Phone Use Adriana Bianchi, James G. Phillips · CyberPsychology & Behavior | Feb 2005 | 1,533 |
| 32 | Nicotine Addiction Neal L. Benowitz · New England Journal of Medicine | 16 Jun 2010 | 1,495 |
| 33 | A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy Peter Hájek, Anna Phillips‐Waller, Dunja Przulj et al. · New England Journal of Medicine | 30 Jan 2019 | 1,480 |
| 34 | Trends in College Binge Drinking During a Period of Increased Prevention Efforts: Findings from 4 Harvard School of Public Health College Alcohol Study Surveys: 1993–2001 Henry Wechsler, Jae Eun Lee, Meichun Mohler‐Kuo et al. · Journal of American College Health | Mar 2002 | 1,466 |
| 35 | Shape of the relapse curve and long‐term abstinence among untreated smokers John R. Hughes, Josue P. Keely, Shelly J. Naud · Addiction | 17 Dec 2003 | 1,447 |
| 36 | Nicotine Chemistry, Metabolism, Kinetics and Biomarkers Neal L. Benowitz, Janne Hukkanen, Peyton Jacob · Handbook of experimental pharmacology | 2009 | 1,439 |
| 37 | Mortality from tobacco in developed countries: indirect estimation from national vital statistics Randolph Peto, Jillian Boreham, Alan D López et al. · The Lancet | May 1992 | 1,419 |
| 38 | Longitudinal tracking of adolescent smoking, physical activity, and food choice behaviors. Steven Harold Kelder, Cheryl L. Perry, Knut‐Inge Klepp et al. · American Journal of Public Health | Jul 1994 | 1,399 |
| 39 | Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation A Randomized Controlled Trial David H. Gonzales · JAMA | 5 Jul 2006 | 1,375 |
| 40 | Assessment of factors affecting the validity of self-reported health-risk behavior among adolescents: evidence from the scientific literature Nancy D. Brener, John O. G. Billy, William R. Grady · Journal of Adolescent Health | 21 Nov 2003 | 1,348 |
| 41 | Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage Jason D. Morrow, Balz Frei, Atkinson W. Longmire et al. · New England Journal of Medicine | 4 May 1995 | 1,343 |
| 42 | Outcome criteria in smoking cessation trials: proposal for a common standard Robert West, Peter Hájek, Lindsay F Stead et al. · Addiction | 25 Feb 2005 | 1,340 |
| 43 | Measuring the Heaviness of Smoking: using self‐reported time to the first cigarette of the day and number of cigarettes smoked per day Todd F. Heatherton, Lynn T. Kozlowski, Richard C. Frecker et al. · British Journal of Addiction | Jul 1989 | 1,338 |
| 44 | Peer influences on college drinking: A review of the research Brian E. Borsari, Kate Bergmann Carey · Journal of Substance Abuse | Dec 2001 | 1,335 |
| 45 | The Association of Cigarette Smoking With Depression and Anxiety: A Systematic Review Meg Fluharty, Amy E. Taylor, Meryem Grabski et al. · Nicotine & Tobacco Research | 19 May 2016 | 1,320 |
| 46 | A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors José de León, Francisco J. Díaz · Schizophrenia Research | 9 Apr 2005 | 1,293 |
| 47 | A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation R. Douglas Hurt, David P.L. Sachs, Elbert D. Glover et al. · New England Journal of Medicine | 23 Oct 1997 | 1,279 |
| 48 | Adverse Childhood Experiences and Smoking During Adolescence and Adulthood Robert F. Anda · JAMA | 3 Nov 1999 | 1,279 |
| 49 | Epidemiology of alcohol and other drug use among American college students. Patrick M. O’Malley, Lloyd D. Johnston · Journal of Studies on Alcohol Supplement | Mar 2002 | 1,278 |
| 50 | Active Smoking and the Risk of Type 2 Diabetes Carole Willi, Patrick Bodenmann, William Amin Ghali et al. · JAMA | 11 Dec 2007 | 1,278 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.